查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467570

2024-2032 年精准精神科市场报告（按产品类型、样本、生物标记类型、技术、应用、最终用户和地区）

Precision Psychiatry Market Report by Product Type, Sample, Biomarker Type, Technology, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球精准精神医学市场规模达10.597亿美元。大众心理健康疾病的盛行率不断上升，对个人化治疗计画和介入措施的需求不断增长，以及基因检测和资料分析的出现，是推动市场发展的一些关键因素。

精准精神医学是指广泛应用于精神健康保健的创新医疗方法。它利用众多先进技术和个人化医疗，为患有精神疾病的个人提供更有针对性和更有效的治疗。它认识到精神疾病，如忧郁症、焦虑症、躁郁症和精神分裂症，是复杂且多方面的疾病，受到遗传、环境和生活方式因素的综合影响。它的目的是根据个人的独特特征（包括基因组成、神经生物学标记和个人情况）定制多种干预措施。它使临床医生能够更深入地了解精神疾病的潜在机制，并相应地制定个人化的治疗计划。除此之外，它还识别出可能导致对某些心理健康状况的易感性或影响对特定药物的反应的特定遗传变异。这些资讯允许选择更合适和更有针对性的治疗方案，增加积极结果的可能性，同时最大限度地减少潜在的不利影响。

精准精神医学市场趋势：

全球市场的主要驱动力是大众心理健康疾病盛行率的上升。加上对个人化治疗计划和干预措施的需求不断增长，个人对精准精神病学的采用大幅增加。由于精准精神医学符合各医学领域个人化医疗的更广泛趋势。它认识到每个人都是独一无二的，需要根据其遗传、神经生物学和环境因素进行客製化治疗。这种个人化的方法引起了患者的共鸣，因为它提供了更有效的治疗和改善的结果的前景，这在大众中获得了广泛的关注。此外，不断的技术进步，例如基因检测、神经影像和资料分析的出现，极大地促进了精准精神病学的发展和实施，进一步对市场产生了有利的影响。除此之外，人们对精准精神医学的兴趣日益浓厚，研究活动和资金支持也不断增加。学术机构、研究组织和製药公司正在投资研究，以更好地了解精神疾病的生物学机制并开发有针对性的治疗方法，从而为市场提供动力。其他因素，包括快速城市化、个人意识的增强以及医疗基础设施的持续发展，也对市场产生积极影响。

本报告回答的关键问题：

  • 迄今为止，全球精准精神医学市场表现如何，未来几年将如何表现？
  • 全球精准精神医学市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球精准精神科市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的精准精神医学市场？
  • 依产品类型分類的市场是怎么样的？
  • 精准精神科市场中最具吸引力的产品类型是什么？
  • 根据样本，市场的细分情况如何？
  • 精准精神医学市场上最具吸引力的样本是什么？
  • 基于生物标誌类型的市场区隔是什么？
  • 精准精神科市场中最具吸引力的生物标记类型是什么？
  • 什么是基于技术的市场分割？
  • 精准精神医学市场中哪一项技术最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 精准精神医学市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 哪个是精准精神医学市场中最具吸引力的最终使用者？
  • 全球精准精神医学市场的竞争结构如何？
  • 全球精准精神科市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球精准精神医学市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 产品
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依样本

  • 血液为基础
    • 市场走向
    • 市场预测
  • 非血液基础
    • 市场走向
    • 关键环节
      • 唾液
      • 尿
      • 脑脊髓液 (CSF)
      • 其他的
    • 市场预测

第 8 章：市场细分：依生物标记类型

  • 基因生物标记
    • 市场走向
    • 市场预测
  • 蛋白质生物标记
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依技术

  • 定序
    • 市场走向
    • 关键环节
      • 新一代定序 (NGS)
      • 桑格定序
    • 市场预测
  • 聚合酶炼式反应 (PCR)
    • 市场走向
    • 关键环节
      • 即时聚合酶炼式反应 (RT-PCR)
      • 数位聚合酶炼式反应 (dPCR)
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • 免疫分析
    • 市场走向
    • 市场预测
  • 液相层析质谱联用 (LC-MS)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按应用

  • 阿兹海默氏症
    • 市场走向
    • 市场预测
  • 帕金森氏症
    • 市场走向
    • 市场预测
  • 自闭症
    • 市场走向
    • 市场预测
  • 沮丧
    • 市场走向
    • 市场预测
  • 双极性情感障碍
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：依最终用户

  • 医院和诊断实验室
    • 市场走向
    • 市场预测
  • 学术研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 12 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 13 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 14 章：价值链分析

第 15 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 16 章：价格分析

第17章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Altimate Healthcare
    • Alto Nanoscience
    • ATAI Life Sciences NV
    • Fulgent Genetics Inc.
    • Invitae Corporation
    • Myriad Genetics Inc.
    • Precision Psychiatric Services Inc.
    • Tempus Labs Inc.
Product Code: SR112024A13298

The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,027.9 Million by 2032, exhibiting a growth rate (CAGR) of 15.5% during 2024-2032. The rising prevalence of mental health disorders among the masses, the growing need for personalized treatment plans and interventions and the advent of genetic testing, and data analytics represent some of the key factors driving the market.

Precision psychiatry refers to an innovative medical approach that is widely adopted for mental health care. It leverages numerous advanced technologies and personalized medicine to provide more targeted and effective treatments for individuals suffering from psychiatric disorders. It recognizes that mental illnesses, such as depression, anxiety, bipolar disorder, and schizophrenia, are complex and multifaceted conditions influenced by a combination of genetic, environmental, and lifestyle factors. It aims to tailor multiple interventions based on an individual's unique characteristics, including their genetic makeup, neurobiological markers, and personal circumstances. It allows clinicians to gain deeper insights into the underlying mechanisms of psychiatric disorders and develop personalized treatment plans accordingly. Besides this, it also identifies specific genetic variations that may contribute to the susceptibility to certain mental health conditions or influence the response to particular medications. This information allows for the selection of more appropriate and targeted treatment options, increasing the likelihood of positive outcomes while minimizing the potential for adverse effects.

Precision Psychiatry Market Trends:

The global market is majorly driven by the rising prevalence of mental health disorders among the masses. Coupled with the growing need for personalized treatment plans and interventions, there has been a considerable increase in the adoption of precision psychiatry among individuals. Since precision psychiatry aligns with the broader trend toward personalized medicine across various medical fields. It recognizes that each individual is unique and requires tailored treatments based on their genetic, neurobiological, and environmental factors. This personalized approach resonates with patients, as it offers the prospect of more effective treatments and improved outcomes, which is gaining widespread prominence among the masses. Moreover, continual technological advancements, such as the advent of genetic testing, neuroimaging, and data analytics have significantly contributed to the development and implementation of precision psychiatry, further impacting the market favorably. Apart from this, the growing interest in precision psychiatry is accompanied by rising research activities and funding support. Academic institutions, research organizations, and pharmaceutical companies are investing in research to better understand the biological mechanisms of psychiatric disorders and develop targeted treatments, hence providing an impetus to the market. Other factors, including rapid urbanization, growing awareness among individuals and continual developments in the healthcare infrastructure, are also positively influencing the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global precision psychiatry market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, sample, biomarker type, technology, application, and end user.

Product Type Insights:

Products

Services

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the product type. This includes products and services. According to the report, products represented the largest segment.

Sample Insights:

Blood-Based

Non-Blood-Based

Saliva

Urine

Cerebral Spinal Fluid (CSF)

Others

A detailed breakup and analysis of the precision psychiatry market based on the sample has also been provided in the report. This includes blood-based and non-blood-based (saliva, urine, cerebral spinal fluid (CSF), and others). According to the report, non-blood-based accounted for the largest market share.

Biomarker Type Insights:

Genetic Biomarker

Protein Biomarker

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the biomarker type. This includes genetic biomarker and protein biomarker. According to the report, protein biomarker exhibits a clear dominance in the market.

Technology Insights:

Sequencing

Next-Generation Sequencing (NGS)

Sanger Sequencing

Polymerase Chain Reaction (PCR)

Real-Time Polymerase Chain Reaction (RT-PCR)

Digital Polymerase Chain Reaction (dPCR)

Microarray

Immunoassay

Liquid Chromatography-Mass Spectrometry (LC-MS)

Others

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the technology. This includes sequencing [next-generation sequencing (NGS) and sanger sequencing], polymerase chain reaction (PCR) [real-time polymerase chain reaction (RT-PCR) and digital polymerase chain reaction (dPCR)], microarray, immunoassay, liquid chromatography-mass spectrometry (LC-MS), and others. According to the report, sequencing represented the largest segment.

Application Insights:

Alzheimer's Disease

Parkinson's Disease

Autism

Depression

Bipolar Disease

Others

A detailed breakup and analysis of the precision psychiatry market based on the application has also been provided in the report. This includes Alzheimer's disease, Parkinson's disease, autism, depression, bipolar disease, and others. According to the report, depression accounted for the largest market share.

End User Insights:

Hospitals and Diagnostic Laboratories

Academic and Research Institutions

Others

The report has provided a detailed breakup and analysis of the precision psychiatry market based on the end user. This includes hospitals and diagnostic laboratories, academic and research institutions and others. According to the report, hospitals and diagnostic laboratories exhibits a clear dominance in the market.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for precision psychiatry. Some of the factors driving the North America precision psychiatry market included the growing awareness among the masses, the emerging healthcare industry, the shifting lifestyle preferences of the masses, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global precision psychiatry market. Detailed profiles of all major companies have been provided. Some of the companies covered include Altimate Healthcare, Alto Nanoscience, ATAI Life Sciences N.V., Fulgent Genetics Inc, Invitae Corporation, Myriad Genetics Inc., Precision Psychiatric Services Inc., Tempus Labs Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global precision psychiatry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision psychiatry market?
  • What is the impact of each driver, restraint, and opportunity on the global precision psychiatry market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision psychiatry market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the precision psychiatry market?
  • What is the breakup of the market based on the sample?
  • Which is the most attractive sample in the precision psychiatry market?
  • What is the breakup of the market based on the biomarker type?
  • Which is the most attractive biomarker type in the precision psychiatry market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision psychiatry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision psychiatry market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the precision psychiatry market?
  • What is the competitive structure of the global precision psychiatry market?
  • Who are the key players/companies in the global precision psychiatry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Psychiatry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample

  • 7.1 Blood-Based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Blood-Based
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Saliva
      • 7.2.2.2 Urine
      • 7.2.2.3 Cerebral Spinal Fluid (CSF)
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Biomarker Type

  • 8.1 Genetic Biomarker
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Protein Biomarker
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Sequencing
    • 9.1.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Next-Generation Sequencing (NGS)
      • 9.2.2.2 Sanger Sequencing
    • 9.1.3 Market Forecast
  • 9.2 Polymerase Chain Reaction (PCR)
    • 9.2.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Real-Time Polymerase Chain Reaction (RT-PCR)
      • 9.2.2.2 Digital Polymerase Chain Reaction (dPCR)
    • 9.2.3 Market Forecast
  • 9.3 Microarray
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Immunoassay
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Liquid Chromatography-Mass Spectrometry (LC-MS)
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Alzheimer's Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Parkinson's Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Autism
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Depression
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Bipolar Disease
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals and Diagnostic Laboratories
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Academic and Research Institutions
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 Drivers, Restraints, and Opportunities

  • 13.1 Overview
  • 13.2 Drivers
  • 13.3 Restraints
  • 13.4 Opportunities

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Altimate Healthcare
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 Alto Nanoscience
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
    • 17.3.3 ATAI Life Sciences N.V.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Fulgent Genetics Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
    • 17.3.5 Invitae Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Myriad Genetics Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Precision Psychiatric Services Inc.
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
    • 17.3.8 Tempus Labs Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Precision Psychiatry Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Psychiatry Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Precision Psychiatry Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Precision Psychiatry Market: Breakup by Sample (in %), 2023
  • Figure 6: Global: Precision Psychiatry Market: Breakup by Biomarker Type (in %), 2023
  • Figure 7: Global: Precision Psychiatry Market: Breakup by Technology (in %), 2023
  • Figure 8: Global: Precision Psychiatry Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Precision Psychiatry Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Precision Psychiatry Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Precision Psychiatry (Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Precision Psychiatry (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Precision Psychiatry (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Precision Psychiatry (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Precision Psychiatry (Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Precision Psychiatry (Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Precision Psychiatry (Non-Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Precision Psychiatry (Non-Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Precision Psychiatry (Genetic Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Precision Psychiatry (Genetic Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Precision Psychiatry (Protein Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Precision Psychiatry (Protein Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Precision Psychiatry (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Precision Psychiatry (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Precision Psychiatry (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Precision Psychiatry (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Precision Psychiatry (Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Precision Psychiatry (Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Precision Psychiatry (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Precision Psychiatry (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Precision Psychiatry (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Precision Psychiatry (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Precision Psychiatry (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Precision Psychiatry (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Precision Psychiatry (Autism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Precision Psychiatry (Autism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Precision Psychiatry (Depression) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Precision Psychiatry (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Precision Psychiatry (Bipolar Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Precision Psychiatry (Bipolar Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Precision Psychiatry (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Precision Psychiatry (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Precision Psychiatry (Academic and Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Precision Psychiatry (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Precision Psychiatry (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Precision Psychiatry (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Asia-Pacific: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Asia-Pacific: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: China: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: China: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Japan: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Japan: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: India: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: India: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: South Korea: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: South Korea: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Australia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Australia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Indonesia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Indonesia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Europe: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Europe: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Germany: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Germany: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: France: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: France: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: United Kingdom: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: United Kingdom: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Italy: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Italy: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Spain: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Spain: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Russia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Russia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Precision Psychiatry Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Precision Psychiatry Industry: Drivers, Restraints, and Opportunities
  • Figure 103: Global: Precision Psychiatry Industry: Value Chain Analysis
  • Figure 104: Global: Precision Psychiatry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Psychiatry Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Precision Psychiatry Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Precision Psychiatry Market Forecast: Breakup by Sample (in Million US$), 2024-2032
  • Table 4: Global: Precision Psychiatry Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
  • Table 5: Global: Precision Psychiatry Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 6: Global: Precision Psychiatry Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Precision Psychiatry Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Precision Psychiatry Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Precision Psychiatry Market: Competitive Structure
  • Table 10: Global: Precision Psychiatry Market: Key Players